{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:18:44Z","timestamp":1783052324765,"version":"3.54.6"},"posted":{"date-parts":[[2026,7,3]]},"group-title":"In Review","reference-count":96,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,16]]},"abstract":"<title>Abstract<\/title>\n                <p>Oxidized phosphatidylcholines (OxPCs) are biomarkers of oxidative stress found in grey matter (GM) lesions during multiple sclerosis (MS), yet their distinct role in GM neurodegeneration remains undefined. Here we report that stereotaxic OxPC deposition in the mouse spinal cord GM induces age dependent neuroinflammation and neurodegeneration. Microglia are the predominant macrophages responding to OxPC induced GM lesions and help to mitigate acute neurodegeneration. Neuronal necroptosis activation in mouse GM lesions and neuronal upregulation of OxPCs and necroptosis activation in MS GM lesions suggest OxPC induced necroptosis promote GM degeneration during MS. In support, necroptosis inhibition ameliorates OxPC induced GM neuron loss. Finally, iron(ii)-containing heme deposition in the GM induces both OxPC formation and neuronal necroptosis activation, suggesting an endogenous upstream mechanism for generating neurotoxic OxPCs. These results highlight a plausible link between heme deposition, lipid peroxidation, and neuronal loss, and that necroptosis inhibition could help prevent GM neurodegeneration during MS.<\/p>","DOI":"10.21203\/rs.3.rs-10050556\/v1","type":"posted-content","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:42:17Z","timestamp":1783050137000},"source":"Crossref","is-referenced-by-count":0,"title":["Grey matter degeneration during multiple sclerosis is linked to activation of neuronal necroptosis by oxidized phosphatidylcholines"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1483-2046","authenticated-orcid":false,"given":"Yifei","family":"Dong","sequence":"first","affiliation":[{"name":"University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoqi","family":"Yu","sequence":"additional","affiliation":[{"name":"University of Saskatchewan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qurat Ul","family":"Ain","sequence":"additional","affiliation":[{"name":"University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaili","family":"Yan","sequence":"additional","affiliation":[{"name":"University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Park","sequence":"additional","affiliation":[{"name":"University of British Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Dignean","sequence":"additional","affiliation":[{"name":"University of Saskatchewan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0812-676X","authenticated-orcid":false,"given":"Stephanie","family":"Zandee","sequence":"additional","affiliation":[{"name":"McGill University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Klement","sequence":"additional","affiliation":[{"name":"Centre de Recherche du Centre Hospitalier de l'Universit\u00e9 de Montr\u00e9al (CRCHUM)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Larouche","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Montr\u00e9al"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zheng","sequence":"additional","affiliation":[{"name":"University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3141-2281","authenticated-orcid":false,"given":"Justin","family":"Botterill","sequence":"additional","affiliation":[{"name":"University of Saskatchewan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-0580","authenticated-orcid":false,"given":"Alexandre","family":"Prat","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Montr\u00e9al\/Centre de Recherche du Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al (CRCHUM)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorian","family":"McGavern","sequence":"additional","affiliation":[{"name":"National Institute of Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jns.2009.01.012","article-title":"Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging","volume":"282","author":"Chard D","year":"2009","unstructured":"Chard D, Miller D (2009) Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging. J Neurol Sci 282:5\u201311. https:\/\/doi.org:10.1016\/j.jns.2009.01.012","journal-title":"J Neurol Sci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/S1474-4422(12)70230-2","article-title":"Measurement and clinical effect of grey matter pathology in multiple sclerosis","volume":"11","author":"Geurts JJ","year":"2012","unstructured":"Geurts JJ, Calabrese M, Fisher E, Rudick RA (2012) Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol 11:1082\u20131092. https:\/\/doi.org:10.1016\/S1474-4422(12)70230-2","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nrn3900","article-title":"Exploring the origins of grey matter damage in multiple sclerosis","volume":"16","author":"Calabrese M","year":"2015","unstructured":"Calabrese M et al (2015) Exploring the origins of grey matter damage in multiple sclerosis. Nat Rev Neurosci 16:147\u2013158. https:\/\/doi.org:10.1038\/nrn3900","journal-title":"Nat Rev Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1093\/brain\/awab132","article-title":"Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement","volume":"144","author":"Ontaneda D","year":"2021","unstructured":"Ontaneda D et al (2021) Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement. Brain 144:1974\u20131984. https:\/\/doi.org:10.1093\/brain\/awab132","journal-title":"Brain"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"fcae355","DOI":"10.1093\/braincomms\/fcae355","article-title":"Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study","volume":"6","author":"Ziccardi S","year":"2024","unstructured":"Ziccardi S et al (2024) Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study. Brain Commun 6:fcae355. https:\/\/doi.org:10.1093\/braincomms\/fcae355","journal-title":"Brain Commun"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg A","year":"2005","unstructured":"Kutzelnigg A et al (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128:2705\u20132712. https:\/\/doi.org:10.1093\/brain\/awh641","journal-title":"Brain"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1136\/jnnp.2008.148767","article-title":"Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord","volume":"80","author":"Gilmore CP","year":"2009","unstructured":"Gilmore CP et al (2009) Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J Neurol Neurosurg Psychiatry 80:182\u2013187. https:\/\/doi.org:10.1136\/jnnp.2008.148767","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/bpa.12813","article-title":"Extensive subpial cortical demyelination is specific to multiple sclerosis","volume":"30","author":"Junker A","year":"2020","unstructured":"Junker A et al (2020) Extensive subpial cortical demyelination is specific to multiple sclerosis. Brain Pathol 30:641\u2013652. https:\/\/doi.org:10.1111\/bpa.12813","journal-title":"Brain Pathol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/bpa.12841","article-title":"B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis","volume":"30","author":"Reali C","year":"2020","unstructured":"Reali C et al (2020) B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis. Brain Pathol 30:779\u2013793. https:\/\/doi.org:10.1111\/bpa.12841","journal-title":"Brain Pathol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/ana.21436","article-title":"Gray matter atrophy in multiple sclerosis: a longitudinal study","volume":"64","author":"Fisher E","year":"2008","unstructured":"Fisher E, Lee JC, Nakamura K, Rudick RA (2008) Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 64:255\u2013265. https:\/\/doi.org:10.1002\/ana.21436","journal-title":"Ann Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1001\/archneurol.2009.174","article-title":"Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis","volume":"66","author":"Calabrese M","year":"2009","unstructured":"Calabrese M et al (2009) Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66:1144\u20131150. https:\/\/doi.org:10.1001\/archneurol.2009.174","journal-title":"Arch Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1212\/01.wnl.0000435551.90824.d0","article-title":"Gray matter damage predicts the accumulation of disability 13 years later in MS","volume":"81","author":"Filippi M","year":"2013","unstructured":"Filippi M et al (2013) Gray matter damage predicts the accumulation of disability 13 years later in MS. Neurology 81:1759\u20131767. https:\/\/doi.org:10.1212\/01.wnl.0000435551.90824.d0","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/ana.25145","article-title":"Deep gray matter volume loss drives disability worsening in multiple sclerosis","volume":"83","author":"Eshaghi A","year":"2018","unstructured":"Eshaghi A et al (2018) Deep gray matter volume loss drives disability worsening in multiple sclerosis. Ann Neurol 83:210\u2013222. https:\/\/doi.org:10.1002\/ana.25145","journal-title":"Ann Neurol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e207768","DOI":"10.1212\/WNL.0000000000207768","article-title":"Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS","volume":"102","author":"Cagol A","year":"2024","unstructured":"Cagol A et al (2024) Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS. Neurology 102:e207768. https:\/\/doi.org:10.1212\/WNL.0000000000207768","journal-title":"Neurology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1111\/febs.12247","article-title":"Oxidized phosphatidylcholines in membrane-level cellular signaling: from biophysics to physiology and molecular pathology","volume":"280","author":"Volinsky R","year":"2013","unstructured":"Volinsky R, Kinnunen PK (2013) Oxidized phosphatidylcholines in membrane-level cellular signaling: from biophysics to physiology and molecular pathology. FEBS J 280:2806\u20132816. https:\/\/doi.org:10.1111\/febs.12247","journal-title":"FEBS J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1093\/brain\/awr128","article-title":"Oxidative damage in multiple sclerosis lesions","volume":"134","author":"Haider L","year":"2011","unstructured":"Haider L et al (2011) Oxidative damage in multiple sclerosis lesions. Brain 134:1914\u20131924. https:\/\/doi.org:10.1093\/brain\/awr128","journal-title":"Brain"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1093\/brain\/awt110","article-title":"Disease-specific molecular events in cortical multiple sclerosis lesions","volume":"136","author":"Fischer MT","year":"2013","unstructured":"Fischer MT et al (2013) Disease-specific molecular events in cortical multiple sclerosis lesions. Brain 136:1799\u20131815. https:\/\/doi.org:10.1093\/brain\/awt110","journal-title":"Brain"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/ana.23974","article-title":"Iron and neurodegeneration in the multiple sclerosis brain","volume":"74","author":"Hametner S","year":"2013","unstructured":"Hametner S et al (2013) Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 74:848\u2013861. https:\/\/doi.org:10.1002\/ana.23974","journal-title":"Ann Neurol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1136\/jnnp-2014-307712","article-title":"Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron","volume":"85","author":"Haider L","year":"2014","unstructured":"Haider L et al (2014) Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosur Ps 85:1386\u20131395. https:\/\/doi.org:10.1136\/jnnp-2014-307712","journal-title":"J Neurol Neurosur Ps"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00401-014-1263-5","article-title":"Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models","volume":"128","author":"Schuh C","year":"2014","unstructured":"Schuh C et al (2014) Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models. Acta Neuropathol 128:247\u2013266. https:\/\/doi.org:10.1007\/s00401-014-1263-5","journal-title":"Acta Neuropathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-021-01059-6","article-title":"Main Role of Antibodies in Demyelination and Axonal Damage in Multiple Sclerosis","author":"Munoz U","year":"2021","unstructured":"Munoz U et al (2021) Main Role of Antibodies in Demyelination and Axonal Damage in Multiple Sclerosis. Cell Mol Neurobiol. https:\/\/doi.org:10.1007\/s10571-021-01059-6","journal-title":"Cell Mol Neurobiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41593-021-00801-z","article-title":"Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia","volume":"24","author":"Dong Y","year":"2021","unstructured":"Dong Y et al (2021) Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. Nat Neurosci 24:489\u2013503. https:\/\/doi.org:10.1038\/s41593-021-00801-z","journal-title":"Nat Neurosci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s43587-022-00205-z","article-title":"Single-cell and spatial RNA sequencing identify perturbators of microglial functions with aging","volume":"2","author":"Dong Y","year":"2022","unstructured":"Dong Y et al (2022) Single-cell and spatial RNA sequencing identify perturbators of microglial functions with aging. Nat Aging 2:508\u2013525. https:\/\/doi.org:10.1038\/s43587-022-00205-z","journal-title":"Nat Aging"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1523\/JNEUROSCI.2312-22.2023","article-title":"Elevated Galectin-3 Is Associated with Aging, Multiple Sclerosis, and Oxidized Phosphatidylcholine-Induced Neurodegeneration","volume":"43","author":"Xue S","year":"2023","unstructured":"Xue S et al (2023) Elevated Galectin-3 Is Associated with Aging, Multiple Sclerosis, and Oxidized Phosphatidylcholine-Induced Neurodegeneration. J neuroscience: official J Soc Neurosci 43:4725\u20134737. https:\/\/doi.org:10.1523\/JNEUROSCI.2312-22.2023","journal-title":"J neuroscience: official J Soc Neurosci"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41593-025-02113-y","article-title":"Oxidized phosphatidylcholines deposition drives chronic neurodegeneration in a mouse model of progressive multiple sclerosis via IL-1beta signaling","volume":"29","author":"Yu R","year":"2026","unstructured":"Yu R et al (2026) Oxidized phosphatidylcholines deposition drives chronic neurodegeneration in a mouse model of progressive multiple sclerosis via IL-1beta signaling. Nat Neurosci 29:67\u201380. https:\/\/doi.org:10.1038\/s41593-025-02113-y","journal-title":"Nat Neurosci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-026-02302-3","article-title":"Foamy microglia link oxylipins to disease progression in multiple sclerosis","author":"Vliet D","year":"2026","unstructured":"van der Vliet D et al (2026) Foamy microglia link oxylipins to disease progression in multiple sclerosis. Nat Neurosci. https:\/\/doi.org:10.1038\/s41593-026-02302-3","journal-title":"Nat Neurosci"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"137ra173","DOI":"10.1126\/scitranslmed.3003831","article-title":"Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation","volume":"4","author":"Ho PP","year":"2012","unstructured":"Ho PP et al (2012) Identification of naturally occurring fatty acids of the myelin sheath that resolve neuroinflammation. Sci Transl Med 4:137ra173. https:\/\/doi.org:10.1126\/scitranslmed.3003831","journal-title":"Sci Transl Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nm1344","article-title":"Lipid microarrays identify key mediators of autoimmune brain inflammation","volume":"12","author":"Kanter JL","year":"2006","unstructured":"Kanter JL et al (2006) Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 12:138\u2013143. https:\/\/doi.org:10.1038\/nm1344","journal-title":"Nat Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00618-8","article-title":"Innate immune detection of lipid oxidation as a threat assessment strategy","author":"Zhivaki D","year":"2021","unstructured":"Zhivaki D, Kagan JC (2021) Innate immune detection of lipid oxidation as a threat assessment strategy. Nat Rev Immunol. https:\/\/doi.org:10.1038\/s41577-021-00618-8","journal-title":"Nat Rev Immunol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.bpj.2011.07.051","article-title":"Oxidized phosphatidylcholines facilitate phospholipid flip-flop in liposomes","volume":"101","author":"Volinsky R","year":"2011","unstructured":"Volinsky R et al (2011) Oxidized phosphatidylcholines facilitate phospholipid flip-flop in liposomes. Biophys J 101:1376\u20131384. https:\/\/doi.org:10.1016\/j.bpj.2011.07.051","journal-title":"Biophys J"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"24842","DOI":"10.1074\/jbc.M702865200","article-title":"Cytotoxic phospholipid oxidation products. Cell death from mitochondrial damage and the intrinsic caspase cascade","volume":"282","author":"Chen R","year":"2007","unstructured":"Chen R, Yang L, McIntyre TM (2007) Cytotoxic phospholipid oxidation products. Cell death from mitochondrial damage and the intrinsic caspase cascade. J Biol Chem 282:24842\u201324850. https:\/\/doi.org:10.1074\/jbc.M702865200","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070002","author":"Halasiddappa LM","year":"2013","unstructured":"Halasiddappa LM, Koefeler H, Futerman AH, Hermetter A (2013) Oxidized Phospholipids Induce Ceramide Accumulation in RAW 264.7 Macrophages: Role of Ceramide Synthases. Plos One 8 https:\/\/doi.org:UNSP e70002 10.1371\/journal.pone.0070002"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"L703","DOI":"10.1152\/ajplung.00539.2020","article-title":"Oxidized phosphatidylcholines induce multiple functional defects in airway epithelial cells","volume":"321","author":"Pascoe CD","year":"2021","unstructured":"Pascoe CD et al (2021) Oxidized phosphatidylcholines induce multiple functional defects in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 321:L703\u2013L717. https:\/\/doi.org:10.1152\/ajplung.00539.2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03118-0","article-title":"Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis","volume":"11","author":"Wiernicki B","year":"2020","unstructured":"Wiernicki B et al (2020) Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis. Cell Death Dis 11. https:\/\/doi.org:ARTN 922 10.1038\/s41419-020-03118-0","journal-title":"Cell Death Dis"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"H1170","DOI":"10.1152\/ajpheart.00237.2020","article-title":"Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia-reperfusion injury","volume":"320","author":"Stamenkovic A","year":"2021","unstructured":"Stamenkovic A et al (2021) Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 320:H1170\u2013H1184. https:\/\/doi.org:10.1152\/ajpheart.00237.2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41586-018-0198-8","article-title":"Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice","volume":"558","author":"Que X","year":"2018","unstructured":"Que X et al (2018) Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice. Nature 558:301\u2013306. https:\/\/doi.org:10.1038\/s41586-018-0198-8","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2019.10.014","article-title":"Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis","author":"Sun X","year":"2019","unstructured":"Sun X et al (2019) Neutralization of Oxidized Phospholipids Ameliorates Non-alcoholic Steatohepatitis. Cell Metab. https:\/\/doi.org:10.1016\/j.cmet.2019.10.014","journal-title":"Cell Metab"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000371","author":"Pesce JT","year":"2009","unstructured":"Pesce JT et al (2009) Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 5, e1000371 https:\/\/doi.org:10.1371\/journal.ppat.1000371"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s40478-019-0850-z","article-title":"Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment","volume":"7","author":"Wageningen TA","year":"2019","unstructured":"van Wageningen TA et al (2019) Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment. Acta Neuropathol Commun 7:206. https:\/\/doi.org:10.1186\/s40478-019-0850-z","journal-title":"Acta Neuropathol Commun"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuron.2014.02.040","article-title":"Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain","volume":"82","author":"Elmore MR","year":"2014","unstructured":"Elmore MR et al (2014) Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain. Neuron 82:380\u2013397. https:\/\/doi.org:10.1016\/j.neuron.2014.02.040","journal-title":"Neuron"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.18153","author":"Fujita S","year":"2023","unstructured":"Fujita S et al (2023) Characterization of Brain Volume Changes in Aging Individuals With Normal Cognition Using Serial Magnetic Resonance Imaging. JAMA Netw Open 6, e2318153 https:\/\/doi.org:10.1001\/jamanetworkopen.2023.18153"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/jnnp-2021-326611","article-title":"Multiple-region grey matter atrophy as a predictor for the development of dementia in a community: the Hisayama Study","volume":"93","author":"Nakazawa T","year":"2022","unstructured":"Nakazawa T et al (2022) Multiple-region grey matter atrophy as a predictor for the development of dementia in a community: the Hisayama Study. J Neurol Neurosurg Psychiatry 93:263\u2013271. https:\/\/doi.org:10.1136\/jnnp-2021-326611","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1212\/WNL.0b013e318230a17d","article-title":"Age and disability accumulation in multiple sclerosis","volume":"77","author":"Scalfari A","year":"2011","unstructured":"Scalfari A, Neuhaus A, Daumer M, Ebers GC, Muraro PA (2011) Age and disability accumulation in multiple sclerosis. Neurology 77:1246\u20131252. https:\/\/doi.org:10.1212\/WNL.0b013e318230a17d","journal-title":"Neurology"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/j.1471-4159.2009.06231.x","article-title":"Oxidized phosphatidylcholine formation and action in oligodendrocytes","volume":"110","author":"Qin JD","year":"2009","unstructured":"Qin JD, Testai FD, Dawson S, Kilkus J, Dawson G (2009) Oxidized phosphatidylcholine formation and action in oligodendrocytes. J Neurochem 110:1388\u20131399. https:\/\/doi.org:10.1111\/j.1471-4159.2009.06231.x","journal-title":"J Neurochem"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00401-021-02274-7","article-title":"Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter","volume":"141","author":"Picon C","year":"2021","unstructured":"Picon C et al (2021) Neuron-specific activation of necroptosis signaling in multiple sclerosis cortical grey matter. Acta Neuropathol 141:585\u2013604. https:\/\/doi.org:10.1007\/s00401-021-02274-7","journal-title":"Acta Neuropathol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000870","article-title":"Interleukin-26, preferentially produced by T(H)17 lymphocytes, regulates CNS barrier function","volume":"7","author":"Broux B","year":"2020","unstructured":"Broux B et al (2020) Interleukin-26, preferentially produced by T(H)17 lymphocytes, regulates CNS barrier function. Neurol Neuroimmunol Neuroinflamm 7. https:\/\/doi.org:10.1212\/NXI.0000000000000870","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/s41423-018-0198-5","article-title":"CD70 defines a subset of proinflammatory and CNS-pathogenic TH1\/TH17 lymphocytes and is overexpressed in multiple sclerosis","volume":"16","author":"Dhaeze T","year":"2019","unstructured":"Dhaeze T et al (2019) CD70 defines a subset of proinflammatory and CNS-pathogenic TH1\/TH17 lymphocytes and is overexpressed in multiple sclerosis. Cell Mol Immunol 16:652\u2013665. https:\/\/doi.org:10.1038\/s41423-018-0198-5","journal-title":"Cell Mol Immunol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"16247","DOI":"10.1074\/jbc.M112.435545","article-title":"Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling","volume":"288","author":"Chen W","year":"2013","unstructured":"Chen W et al (2013) Diverse sequence determinants control human and mouse receptor interacting protein 3 (RIP3) and mixed lineage kinase domain-like (MLKL) interaction in necroptotic signaling. J Biol Chem 288:16247\u201316261. https:\/\/doi.org:10.1074\/jbc.M112.435545","journal-title":"J Biol Chem"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.molcel.2014.10.021","article-title":"RIP3 induces apoptosis independent of pronecrotic kinase activity","volume":"56","author":"Mandal P","year":"2014","unstructured":"Mandal P et al (2014) RIP3 induces apoptosis independent of pronecrotic kinase activity. Mol Cell 56:481\u2013495. https:\/\/doi.org:10.1016\/j.molcel.2014.10.021","journal-title":"Mol Cell"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1038\/s41591-025-03625-7","article-title":"Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis","volume":"31","author":"Klotz L","year":"2025","unstructured":"Klotz L et al (2025) Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis. Nat Med 31:2016\u20132026. https:\/\/doi.org:10.1038\/s41591-025-03625-7","journal-title":"Nat Med"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/brain\/awaa436","article-title":"Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI","volume":"144","author":"Dal-Bianco A","year":"2021","unstructured":"Dal-Bianco A et al (2021) Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI. Brain 144:833\u2013847. https:\/\/doi.org:10.1093\/brain\/awaa436","journal-title":"Brain"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1016\/S0021-9258(18)67521-0","article-title":"The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation","volume":"261","author":"Braughler JM","year":"1986","unstructured":"Braughler JM, Duncan LA, Chase RL (1986) The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation. J Biol Chem 261:10282\u201310289","journal-title":"J Biol Chem"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1148\/radiol.2016160060","article-title":"Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study","volume":"281","author":"Zivadinov R","year":"2016","unstructured":"Zivadinov R et al (2016) Cerebral Microbleeds in Multiple Sclerosis Evaluated on Susceptibility-weighted Images and Quantitative Susceptibility Maps: A Case-Control Study. Radiology 281:884\u2013895. https:\/\/doi.org:10.1148\/radiol.2016160060","journal-title":"Radiology"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"e70595","DOI":"10.1111\/ene.70595","article-title":"Erythrocyte Fragility in Progressive Multiple Sclerosis","volume":"33","author":"Jacob C","year":"2026","unstructured":"Jacob C et al (2026) Erythrocyte Fragility in Progressive Multiple Sclerosis. Eur J Neurol 33:e70595. https:\/\/doi.org:10.1111\/ene.70595","journal-title":"Eur J Neurol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.12688\/wellcomeopenres.9967.2","article-title":"Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosis","volume":"1","author":"Lewin A","year":"2016","unstructured":"Lewin A et al (2016) Free serum haemoglobin is associated with brain atrophy in secondary progressive multiple sclerosis. Wellcome Open Res 1:10. https:\/\/doi.org:10.12688\/wellcomeopenres.9967.2","journal-title":"Wellcome Open Res"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"109898","DOI":"10.1016\/j.celrep.2021.109898","article-title":"Proteomic and lipidomic profiling of demyelinating lesions identifies fatty acids as modulators in lesion recovery","volume":"37","author":"Penkert H","year":"2021","unstructured":"Penkert H et al (2021) Proteomic and lipidomic profiling of demyelinating lesions identifies fatty acids as modulators in lesion recovery. Cell Rep 37:109898. https:\/\/doi.org:10.1016\/j.celrep.2021.109898","journal-title":"Cell Rep"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"eadw5197","DOI":"10.1126\/sciimmunol.adw5197","article-title":"Monocyte-derived macrophages drive neurological tissue damage through mitochondrial reactive oxygen species","volume":"11","author":"Villar-Vesga J","year":"2026","unstructured":"Villar-Vesga J et al (2026) Monocyte-derived macrophages drive neurological tissue damage through mitochondrial reactive oxygen species. Sci Immunol 11:eadw5197. https:\/\/doi.org:doi:10.1126\/sciimmunol.adw5197","journal-title":"Sci Immunol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jneuroim.2018.10.009","article-title":"The role of expression and activity of 15-Lipoxygenase isoforms and related cytokines in patients with Multiple Sclerosis and healthy controls","volume":"325","author":"Safizadeh B","year":"2018","unstructured":"Safizadeh B et al (2018) The role of expression and activity of 15-Lipoxygenase isoforms and related cytokines in patients with Multiple Sclerosis and healthy controls. J Neuroimmunol 325:32\u201342. https:\/\/doi.org:10.1016\/j.jneuroim.2018.10.009","journal-title":"J Neuroimmunol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aau2293","article-title":"Enzymatically oxidized phospholipids assume center stage as essential regulators of innate immunity and cell death","volume":"12","author":"O'Donnell VB","year":"2019","unstructured":"O'Donnell VB, Aldrovandi M, Murphy RC, Kronke G (2019) Enzymatically oxidized phospholipids assume center stage as essential regulators of innate immunity and cell death. Sci Signal 12. https:\/\/doi.org:10.1126\/scisignal.aau2293","journal-title":"Sci Signal"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aay6324","article-title":"Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion","volume":"6","author":"Plemel JR","year":"2020","unstructured":"Plemel JR et al (2020) Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion. Sci Adv 6. https:\/\/doi.org:ARTN eaay6324 10.1126\/sciadv.aay6324","journal-title":"Sci Adv"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"342766","DOI":"10.1016\/j.aca.2024.342766","article-title":"Quantitative analysis of heme and hemoglobin for the detection of intravascular hemolysis","volume":"1312","author":"Hopp MT","year":"2024","unstructured":"Hopp MT et al (2024) Quantitative analysis of heme and hemoglobin for the detection of intravascular hemolysis. Anal Chim Acta 1312:342766. https:\/\/doi.org:10.1016\/j.aca.2024.342766","journal-title":"Anal Chim Acta"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323951","article-title":"Cerebral microbleeds: from depiction to interpretation","author":"Puy L","year":"2021","unstructured":"Puy L et al (2021) Cerebral microbleeds: from depiction to interpretation. J Neurol Neurosurg Psychiatry. https:\/\/doi.org:10.1136\/jnnp-2020-323951","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1002\/jnr.21206","article-title":"Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain","volume":"85","author":"Qin J","year":"2007","unstructured":"Qin J, Goswami R, Balabanov R, Dawson G (2007) Oxidized phosphatidylcholine is a marker for neuroinflammation in multiple sclerosis brain. J Neurosci Res 85:977\u2013984. https:\/\/doi.org:10.1002\/jnr.21206","journal-title":"J Neurosci Res"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.freeradbiomed.2019.05.027","article-title":"Analysis of fragmented oxidized phosphatidylcholines in human plasma using mass spectrometry: Comparison with immune assays","volume":"144","author":"Philippova M","year":"2019","unstructured":"Philippova M et al (2019) Analysis of fragmented oxidized phosphatidylcholines in human plasma using mass spectrometry: Comparison with immune assays. Free Radic Biol Med 144:167\u2013175. https:\/\/doi.org:10.1016\/j.freeradbiomed.2019.05.027","journal-title":"Free Radic Biol Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.70938","article-title":"A highly conserved host lipase deacylates oxidized phospholipids and ameliorates acute lung injury in mice","volume":"10","author":"Zou B","year":"2021","unstructured":"Zou B et al (2021) A highly conserved host lipase deacylates oxidized phospholipids and ameliorates acute lung injury in mice. Elife 10. https:\/\/doi.org:10.7554\/eLife.70938","journal-title":"Elife"},{"key":"ref66","unstructured":"METHODS"},{"key":"ref67","author":"Specimens MS","unstructured":"Specimens MS"},{"key":"ref68","unstructured":"Post-mortem human brain tissues were obtained from six patients (aged 48\u201365 years old, 2 females and 4 males) diagnosed with clinical and neuropathological secondary progressive MS according to the revised 2010 McDonald\u2019s criteria66,67, with full ethical approval (BH07.001, Nagano 20.332 - YP) and informed consent as approved by the CRCHUM and University of Montreal research ethics committee. As previously described46,47, autopsy samples were cryopreserved, and lesions were classified using Luxol fast blue and H&E staining"},{"key":"ref69","author":"Mice","unstructured":"Mice"},{"key":"ref70","unstructured":"All experiments were conducted with ethics approval (protocol number 20220103) from the Animal Care Committee at the University of Saskatchewan under regulations of the Canadian Council of Animal Care Six-week-old Female C57Bl\/6NCrl mice were acquired from Charles River Laboratories (strain 027) and were used for most in vivo experiments between 8-12wk old, whereas female 6wk and 52wk old C57Bl\/6J mice were acquired from the Jackson Laboratory (strain 000664) for experiments studying the effect of age. Tmem119creERT2 mice (strain 031820)68, Ai9TdTom mice (strain 007909)69, and Rosa26iDTR mice (strain 007900)70 from the Jackson Laboratory were bred in the Lab Animal Services Unit at the University of Saskatchewan to produce male and female Tmem119CreERT2:Ai9TdTom mice and Tmem119CreERT2:Rosa26iDTR mice for microglial lineage tracing and depletion studies, respectively. Mice were maintained on a regular diet in a low humidity environment on a 12-hr light\/dark cycle at 21 to 23\u00b0C with unlimited access to food and water. Mice and littermates were randomly assigned to different experimental groups"},{"key":"ref71","author":"Spinal","unstructured":"Spinal cord surgery"},{"key":"ref72","unstructured":"OxPC injection into the spinal cord GM was performed as described previously22 ,71, except that the depth of the injection was modified to target the GM rather than then WM. In brief, mice were anesthetized with subcutaneous injection of ketamine (100 mg\/kg) and xylazine (10 mg\/kg). Metacam (5 mg\/kg) was injected subcutaneously as analgesic. Following dissection to expose the spinal cord between the T3 and T4 vertebrae, 0.5 \u00b5L of 10 mg\/mL of POVPC (Sigma, 870606P) diluted in sterile PBS was injected at a depth of 0.9 mm with a rate of 0.25 \u00b5L\/min. After injection, the needle was retained in place for 2 minutes to prevent liquid backflow. The mouse was then sutured, and bupivacaine (5 mg\/kg) was applied along the suture as additional analgesic. Mice were also injected with atipamezole (100 mg\/kg) intraperitoneally to reverse the effect of xylazine as well as slow-release buprenorphine (1 mg\/kg) subcutaneously for extended pain relief. Finally, mice were placed in a thermally controlled environment for recovery"},{"key":"ref73","unstructured":"Iron(ii)-containing heme preparation"},{"key":"ref74","unstructured":"In a biosafety cabinet and avoiding light, iron(ii)-containing heme or ferroprotoporphyrin (Cayman Chemicals 34327) was first dissolved in 0.1M NaOH and then diluted 1:10 in sterile PBS (pH 7.4) to a final concentration of 2 mg\/mL or 10 mg\/mL. Solutions were then sterile filtered with a 0.22 \u00b5m syringe filter (Fisher Scientific) immediately prior to use. Using the spinal cord surgery method described above to induce spinal cord GM lesions, 0.5 \u00b5L of 2 mg\/mL solution was injected into the spinal cord GM for a final dose of 1 \u00b5g per mouse whereas 0.5 \u00b5L of 10 mg\/mL solution was injected for a final dose of 5 \u00b5g per mouse"},{"key":"ref75","author":"Lineage","unstructured":"Lineage tracing microglia"},{"key":"ref76","article-title":"CreER:Ai9tdTom mice were intraperitoneally injected with 2 mg of tamoxifen (20 mg\/mL; T5648, Sigma) dissolved in corn oil (C8267) once a day for 5 consecutive days followed by another 5 consecutive days with 2 days in between two set of injections to induce Tdtomato expression in Tmem119+ microglia. Tamoxifen treated mice were used for experiments 3 days after the final tamoxifen injection","author":"Six-week-old Tmem119","unstructured":"Six-week-old Tmem119 CreER:Ai9tdTom mice were intraperitoneally injected with 2 mg of tamoxifen (20 mg\/mL; T5648, Sigma) dissolved in corn oil (C8267) once a day for 5 consecutive days followed by another 5 consecutive days with 2 days in between two set of injections to induce Tdtomato expression in Tmem119+ microglia. Tamoxifen treated mice were used for experiments 3 days after the final tamoxifen injection"},{"key":"ref77","author":"Microglia","unstructured":"Microglia depletion"},{"key":"ref78","article-title":"Rosa26iDTR mice were injected intraperitoneally with 2 mg tamoxifen (20 mg\/ml; T5648, Sigma) dissolved in corn oil (C8267) once a day for 5 consecutive days to induce diphtheria toxin receptor expression in microglia. Three days after the final injection, tamoxifen treated Tmem119CreERT2: Rosa26iDTR mice were injected intraperitoneally with either PBS as controls or 1 \u00b5g of diphtheria toxin daily from days 0 to 7 after POVPC spinal cord injection","author":"Tmem119CreERT2","unstructured":"Tmem119CreERT2 Rosa26iDTR mice were injected intraperitoneally with 2 mg tamoxifen (20 mg\/ml; T5648, Sigma) dissolved in corn oil (C8267) once a day for 5 consecutive days to induce diphtheria toxin receptor expression in microglia. Three days after the final injection, tamoxifen treated Tmem119CreERT2: Rosa26iDTR mice were injected intraperitoneally with either PBS as controls or 1 \u00b5g of diphtheria toxin daily from days 0 to 7 after POVPC spinal cord injection"},{"key":"ref79","author":"Alternatively","unstructured":"Alternatively, C57BL\/6 NCrl mice were given normal chow or chow (Envigo) formulated with 300 mg\/kg the CSF1R inhibitor PLX339740 (Adooq) ad libitum for 2 weeks prior to experiments. After POVPC injection in the spinal cord GM, mice were kept on control or PLX3397 diet for another 7 days until tissues were collected for analysis"},{"key":"ref80","unstructured":"GSK-872 inhibition of RIPK3"},{"key":"ref81","unstructured":"GSK-872 (MedChemExpress HY-101872) was dissolved in DMSO into a 10 mM stock solution in DMSO for storage. For experiments, the stock solution was diluted with corn oil so that the final working solution is 10% DMSO and 90% corn oil. Mice were intraperitoneal injected with 20 mg\/kg of GSK-872 once a day after POVPC injection and tissues were collected after 3 days for analysis. Mice treated with 10% DMSO and 90% corn oil without GSK-872 were used as controls"},{"key":"ref82","unstructured":"Spinal cord tissue isolation for histology and microscopy analysis"},{"key":"ref83","author":"One-","unstructured":"One- 3-, 7-, or 14-days post spinal cord injection, mice were overdosed with isoflurane. Thereafter, 10 mL of ice-cold PBS followed by 10 mL of ice-cold 4% paraformaldehyde in PBS were perfused via cardiac puncture. The spinal cord was then dissected from the back of the mouse, and the tissue containing the lesion was collected into 4% paraformaldehyde in PBS for fixation overnight at 4 degrees. Afterwards, spinal cords were transferred to 30% sucrose solution for dehydration for at least 48 h and frozen in FSC 22 Frozen Section Media (Leica). Using a cryostat (ThermoFisher Scientific), spinal cord tissue was then cut coronally into 20 \u00b5m sections and collected on to Superfrost Plus microscope slides (VWR). All tissues were stored at -20 degrees prior to staining and analysis"},{"key":"ref84","author":"Antibodies","unstructured":"Antibodies"},{"key":"ref85","unstructured":"The following primary antibodies were used for immunofluorescence microscopy: mouse E06 IgM anti-OxPC (1:200, Absolute Antibody Ab02746-21.0 and Sigma MABS2278), chicken anti-human\/mouse IBA1 (1:500, Synaptic Systems 234009), rabbit anti-mouse IBA1 (1:1000, Wako 019-19741), chicken anti-mouse GFAP (1:1000, Biolegend 829401), rabbit anti-mouse p22phox (1:200, Cell Signaling 37570S), rat anti-human\/mouse NeuN (1:400, Abcam ab177487), rabbit anti-mouse cleaved caspase-3 (1:200, Cell Signaling 9661S), rabbit anti-mouse pRIPK3 (1:300, Cell Signaling 91702S), rabbit anti-mouse pMLKL (1:500, Cell Signaling 37333T), rabbit anti-human pMLKL (1:100, R&D Systems MAB9187), rat anti-mouse CD11b (1:200, ThermoFisher 14-0112-82), rat anti-mouse iNOS (1:100, ThermoFisher 14-5920-82), rabbit anti-mouse Arg1 (1:200, Cell Signaling 93668S), rabbit anti-human\/mouse Ki67 (1:200, Abcam ab15580), rabbit anti-mouse GluA2 (1:500, Abcam ab133477), rabbit anti-mouse VGLUT2 (1:500, Synaptic Systems 135408), mouse anti-mouse Tuj1 (1:400, Biolegend 801202), rabbit anti-mouse TNF-\u03b1 (0.34 \u00b5g\/mL, Cell Signaling 11948), rabbit IgG isotype control (0.34 \u00b5g\/mL, ThermoFisher 02-6102)"},{"key":"ref86","article-title":"ImmunoResearch were used at 1:400 dilution: Alexa Fluor 488 donkey anti-mouse IgM, Alexa Fluor 647 donkey anti-mouse IgM, Alexa Fluor 488 donkey anti-mouse IgG, Cyanine Cy3 donkey anti-chicken IgY, Alexa Fluor 647 donkey anti-rat IgG, Cyanine Cy3 donkey anti-rat IgG, Alexa Fluor 488 donkey anti-rabbit IgG, and Alexa Fluor 647 donkey anti-rabbit IgG","author":"The following secondary antibodies from Jackson","unstructured":"The following secondary antibodies from Jackson ImmunoResearch were used at 1:400 dilution: Alexa Fluor 488 donkey anti-mouse IgM, Alexa Fluor 647 donkey anti-mouse IgM, Alexa Fluor 488 donkey anti-mouse IgG, Cyanine Cy3 donkey anti-chicken IgY, Alexa Fluor 647 donkey anti-rat IgG, Cyanine Cy3 donkey anti-rat IgG, Alexa Fluor 488 donkey anti-rabbit IgG, and Alexa Fluor 647 donkey anti-rabbit IgG"},{"key":"ref87","unstructured":"Labeling tissues for immunofluorescence microscopy"},{"key":"ref88","author":"As","unstructured":"As previously described22\u201325, slides with mouse spinal cord samples were warmed to room temperature (RT) for 30 min. Tissues were rehydrated with PBS for 10 min and permeabilized with PBS with 0.2% Triton X-100 (Sigma) for 10 min. Blocking buffer (PBS, 10% donkey serum, 0.1% cold water fish gelatin, 0.1% Triton X-100, 0.05% Tween-20) was used to block non-specific binding for 1 h at room temperature in a humidity chamber. Alternatively, E06 IgM antibody staining, 5 \u00b5g\/ml of purified Rat Anti-Mouse CD16\/CD32 Fc blocking antibody (5 \u00b5g\/ml, BD Pharmingen) was added to the blocking buffer. Afterwards, primary antibodies diluted in antibody dilution buffer (PBS, 0.1% cold fish gelatin, and 0.5% Triton X-100) were added onto microscopy slides and incubated overnight at 4 degrees. Next, slides were washed using PBS with 0.05% Tween-20 (Sigma) thrice for 5 minutes. Thereafter, tissues were incubated with secondary antibodies and DAPI (2 \u00b5g\/mL, Sigma) diluted in antibody dilution buffer for 1 h at room temperature. For samples with potential high autofluorescence, slides were also blocked using the TrueBlack Lipofuscin Autofluorescence Quencher (Biotium) in accordance with manufacturer\u2019s instructions. Finally, slides were washed thrice using PBS with 0.5% Tween-20, 5 min each, and coverslips were mounted onto the slides using Fluoromount-G solution (SouthernBiotech)"},{"key":"ref89","author":"Immunofluorescence","unstructured":"Immunofluorescence microscopy"},{"key":"ref90","article-title":"7 LED illumination and a 10 x 0.45NA air objective for all samples, followed by default background subtraction. Excitation wavelengths at 405 nm, 488 nm, 552 nm and 640 nm were used to excite fluorophore-conjugated on secondary antibodies. Image acquisition settings including pixel size (0.274 \u00b5m\/pixel), bit rate, binning (1x1), exposure time, and gain (4X) were kept equal across all samples for each experiment to prevent sample collection bias. A sample slide stained with only secondary antibodies and DAPI was used for each experiment to control for non-specific secondary immunofluorescence. The lesion epicenter as determined by the largest lesion area in any given section for each mouse was acquired for data analysis. Alternatively, images of all serial sections that contain lesions (each 400 \u00b5m apart) for each spinal cord were acquired for lesion volume analysis","author":"Immunofluorescence images were acquired at room temperature using the Zeiss Axio Observer 7 widefield microscope with Colibri","unstructured":"Immunofluorescence images were acquired at room temperature using the Zeiss Axio Observer 7 widefield microscope with Colibri 7 LED illumination and a 10 x 0.45NA air objective for all samples, followed by default background subtraction. Excitation wavelengths at 405 nm, 488 nm, 552 nm and 640 nm were used to excite fluorophore-conjugated on secondary antibodies. Image acquisition settings including pixel size (0.274 \u00b5m\/pixel), bit rate, binning (1x1), exposure time, and gain (4X) were kept equal across all samples for each experiment to prevent sample collection bias. A sample slide stained with only secondary antibodies and DAPI was used for each experiment to control for non-specific secondary immunofluorescence. The lesion epicenter as determined by the largest lesion area in any given section for each mouse was acquired for data analysis. Alternatively, images of all serial sections that contain lesions (each 400 \u00b5m apart) for each spinal cord were acquired for lesion volume analysis. Zeiss Zen (v3.9) software was used for image acquisition.","journal-title":"Zeiss Zen"},{"key":"ref91","author":"Image","unstructured":"Image analysis"},{"key":"ref92","unstructured":"Images were analyzed using ImageJ 1.54f (Fiji, NIH) as previously described25. In brief, the raw grey scale images for each channel\/marker were converted to RGB, and region of interest (ROI) was drawn around the mouse spinal cord grey matter on the ipsilateral GM side where POVPC was injected (also contralateral NAGM for certain analyses). To analyze immunoreactivity within GM, the area outside the ROI was first cleared, and the same color threshold values were used consistently to identify positive signals for each channel\/marker across all samples in each set of experiments to prevent analysis bias. The analyze particles function was then used to quantify the positive signals in each ROI. The same size and circularity settings for particle analysis were used for all samples in each experimental set. For representative images shown, channels\/markers for each sample were merged and displayed using pseudo colors. Only brightness and contrast settings were adjusted in ImageJ, and consistently between samples for better displaying the images"},{"key":"ref93","author":"Mouse","unstructured":"Mouse cortical neuron culture"},{"key":"ref94","unstructured":"Mouse-derived neurons were cultured as previously described72. Briefly, brains were collected from mice embryos at embryonic days E16-18 and cortical neurons were isolated and cultured in neurobasal plus medium (ThermoFisher, 21103049) with B-27 plus supplement (ThermoFisher, A3653401) in T-25 tissue culture flasks (BD Falcon). After 2 days in culture, cortical neurons were detached from the T-25 flasks using 1x Versene solution with 0.25% trypsin and 1 mg\/mL DNase I and seeded onto 96-well plates at a density of 5 x 104 neurons per well, and plates were incubated at 37 degrees in a 5% CO2 incubator. Five to 6 days later, neurons were treated with either media alone as the control, with 50 \u00b5M PC (Sigma, P1652), or 50 \u00b5M POVPC for 24 h. Afterwards, neurons were fixed with PBS containing 4% paraformaldehyde for 30 minutes at room temperature and were washed with PBS thrice for 5 min. For immunofluorescence microscopy analysis, cells were permeabilized in 1 x PBS with 0.2% Triton-X for 10 minutes, then incubated in donkey blocking buffer for 1 h before incubating in primary antibodies overnight in 4 degrees. Thereafter, cells were washed in 1 x PBS with 0.05% Tween-20 thrice for 5 minutes and incubated with antibody dilution buffer containing secondary antibodies and DAPI for 1h at room temperature. Finally, cells were washed in PBS with 0.05% Tween-20 thrice for 5 min and resuspended in PBS. Images of labeled neurons in 96 well plates were acquired using the Zeiss Axio Observer 7 widefield microscope as described above. Specifically, 9 fields-of-views were collected per well for quantitative analysis as described above"},{"key":"ref95","author":"Statistics","unstructured":"Statistics and reproducibility"},{"key":"ref96","unstructured":"All data were collated in Microsoft Excel (v2605) and graphs were generated using GraphPad Prism 10.6.1 (LaJolla, CA). Data are shown as individual data points where each point on a graph represents a separate mouse for in vivo experiments, or a separate well for neuron culture experiments. The mean\u2009\u00b1\u2009SD are also shown. While no power calculation was performed, the sample size was determined based on previously published results22\u201325 as well as the cost of experiment, feasibility of the experiment, as well as the availability of sex and aged matched mice. Approximately 5 percent of mice in experiments had failed injections with no apparent GM injury, and these animals were not analyzed. Otherwise, no data was excluded from the study. Sample sizes are reported in the figure legends and only one measurement is recorded per sample. Littermate mice were selected randomly for each experiment and treatment groups. Data collection and analysis were not performed blindly to the experimental condition since quantitative analyses were performed using equal acquisition and analysis settings across all samples for each experiment. To analyze the statistical differences between the means of two or more treatment groups against each other, one-way ANOVA with Tukey\u2019s multiple comparison test was used, while one-way ANOVA with Dunnett\u2019s multiple comparisons test was used to compare two or more treatment groups against the control group. Two-tailed, unpaired t-test was used to compare data with only two groups. Kolmogorov-Smirnov test was used to verify the normal distribution of data. Specific p-values are reported in each figure where results are considered statistically significant where p\u2009<\u20090.05"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10050556\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10050556\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T03:42:37Z","timestamp":1783050157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10050556\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":96,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10050556\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,7,3]]},"subtype":"preprint"}}